These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Inhibition of cholesterol synthesis with the use of Mer-29. OAKS W; LISAN P; MOYER JM Arch Intern Med; 1959 Oct; 104():527-31. PubMed ID: 14428135 [No Abstract] [Full Text] [Related]
23. Clinical observations on the effects of MER-29. KOUNTZ WB Prog Cardiovasc Dis; 1960 May; 2():541-3. PubMed ID: 14411340 [No Abstract] [Full Text] [Related]
24. The use of triparanol to lower serum cholesterol. GOYETTE EM; ELDER JC Am Heart J; 1960 Oct; 60():536-8. PubMed ID: 13707585 [No Abstract] [Full Text] [Related]
25. The mechanism of action of MER-29. AVIGAN J; STEINBERG D; THOMPSON MJ; MOSETTIG E Prog Cardiovasc Dis; 1960 May; 2():525-30. PubMed ID: 13795275 [No Abstract] [Full Text] [Related]
26. The toxicology of MER-29. KING WM Prog Cardiovasc Dis; 1960 May; 2():504-8. PubMed ID: 14409210 [No Abstract] [Full Text] [Related]
27. The metabolism of desmosterol in human subjects during triparanol administration. GOODMAN DS; AVIGAN J; WILSON H J Clin Invest; 1962 May; 41(5):962-71. PubMed ID: 13900301 [No Abstract] [Full Text] [Related]
28. Mechanism of action of MER-29, an inhibitor of cholesterol biosynthesis. AVIGAN J; STEINBERG D; THOMPSON MJ; MOSETTIG E Biochem Biophys Res Commun; 1960 Jan; 2():63-5. PubMed ID: 13795274 [No Abstract] [Full Text] [Related]
29. Basic research leading to MER-29. PALOPOLI FP Prog Cardiovasc Dis; 1960 May; 2():489-91. PubMed ID: 14430035 [No Abstract] [Full Text] [Related]
30. A study of MER-29 in experimental animals. PORTMAN OW; MAYER J; HEGSTED DM Prog Cardiovasc Dis; 1960 May; 2():531-5. PubMed ID: 14434304 [No Abstract] [Full Text] [Related]
31. Effects of triparanol on serum low-density lipoproteins and cholesterol. ENGELBERG H Geriatrics; 1962 Aug; 17():528-31. PubMed ID: 13890232 [No Abstract] [Full Text] [Related]
32. The treatment of hypercholesterolaemia by MER-29. JOSE AD; LEAROYD B; PEAK H Med J Aust; 1961 Dec; 48(2)():938-43. PubMed ID: 14452498 [No Abstract] [Full Text] [Related]
33. Effect of triparanol (MER/29) on corticosterone secretion by rat adrenals. HOLLOSZY J; EISENSTEIN AB Proc Soc Exp Biol Med; 1961 Jun; 107():347-9. PubMed ID: 13715399 [No Abstract] [Full Text] [Related]
34. Control of serum lipids by diet and triparanol (MER 29). WILLIAMS GE; GADDIE R; SINGH SP J Atheroscler Res; 1962; 2():96-103. PubMed ID: 14007156 [No Abstract] [Full Text] [Related]
35. Complications in the use of triparanol (MER-29). Report of a case of ichthyosis, loss of hair, and change in hair color. PERRY HO; WINKELMANN RK; ACHOR RW Minn Med; 1962 Jun; 45():597-600. PubMed ID: 14485572 [No Abstract] [Full Text] [Related]
36. Evaluation of the administration of MER-29 to a group of institutionalized patients at the St. Louis Chronic Hospital: a preliminary report. TORO J Prog Cardiovasc Dis; 1960 May; 2():544-7. PubMed ID: 13838916 [No Abstract] [Full Text] [Related]
37. A clinical study of MER-29 in patients with angina pectoris. HALPERIN MH Prog Cardiovasc Dis; 1960 May; 2():631-6. PubMed ID: 14399143 [No Abstract] [Full Text] [Related]
38. [Action of triparanol on blood lipid changes]. MARCHESE G G Gerontol; 1962 May; 10():449-61. PubMed ID: 14469633 [No Abstract] [Full Text] [Related]
39. Note on MER-29 in arteriosclerotic heart disease. CORCORAN AC; ZIMMERMAN HA; CUTURELLI R Prog Cardiovasc Dis; 1960 May; 2():576-7. PubMed ID: 13811921 [No Abstract] [Full Text] [Related]
40. Inhibition by triparanol of cholesterol formation in the brain of the newborn mouse. SCALLEN TJ; CONDIE RM; SCHROEPFER GJ J Neurochem; 1962; 9():99-103. PubMed ID: 14497769 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]